Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4(1h)-pyridinone, 2,3-dihydro-1-(2,3,6-trifluoro-4-((5s)-5-((3-isoxazolylamino)methyl)-2-oxo-3-oxazolidinyl)phenyl)-
2. 5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2h)-yl)phenyl)oxazolidin-2-one
3. Mrx-i Compound
1. Mrx-i
2. 1112968-42-9
3. Mrx-1
4. Contezolid [usan]
5. B669m62elp
6. Chembl3287379
7. (5s)-5-[(1,2-oxazol-3-ylamino)methyl]-3-[2,3,5-trifluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidin-2-one
8. (s)-5-((isoxazol-3-ylamino)methyl)-3-(2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2h)-yl)phenyl)oxazolidin-2-one
9. 4(1h)-pyridinone, 2,3-dihydro-1-(2,3,6-trifluoro-4-((5s)-5-((3-isoxazolylamino)methyl)-2-oxo-3-oxazolidinyl)phenyl)-
10. Unii-b669m62elp
11. Youxitai
12. Contezolid [inn]
13. Contezolid (usan/inn)
14. Contezolid [who-dd]
15. Schembl5945221
16. Gtpl10795
17. Bdbm50017203
18. Db12796
19. Hy-19915
20. Cs-0016941
21. D11297
22. Q27274420
23. 1-(2,3,6-trifluoro-4-((5s)-5-((1,2-oxazol-3-ylamino)methyl)-2-oxo-1,3-oxazolidin-3-yl)phenyl)-2,3-dihydropyridin-4(1h)-one
24. 1-{2,3,6-trifluoro-4-[(5s)-5-{[(1,2-oxazol-3-yl)amino]methyl}-2-oxo-1,3-oxazolidin-3-yl]phenyl}-2,3-dihydropyridin-4(1h)-one
25. Zc0
| Molecular Weight | 408.3 g/mol |
|---|---|
| Molecular Formula | C18H15F3N4O4 |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 408.10453946 g/mol |
| Monoisotopic Mass | 408.10453946 g/mol |
| Topological Polar Surface Area | 87.9 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 669 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
36
PharmaCompass offers a list of Contezolid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Contezolid manufacturer or Contezolid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Contezolid manufacturer or Contezolid supplier.
PharmaCompass also assists you with knowing the Contezolid API Price utilized in the formulation of products. Contezolid API Price is not always fixed or binding as the Contezolid Price is obtained through a variety of data sources. The Contezolid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Contezolid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Contezolid, including repackagers and relabelers. The FDA regulates Contezolid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Contezolid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Contezolid supplier is an individual or a company that provides Contezolid active pharmaceutical ingredient (API) or Contezolid finished formulations upon request. The Contezolid suppliers may include Contezolid API manufacturers, exporters, distributors and traders.
Contezolid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Contezolid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Contezolid GMP manufacturer or Contezolid GMP API supplier for your needs.
A Contezolid CoA (Certificate of Analysis) is a formal document that attests to Contezolid's compliance with Contezolid specifications and serves as a tool for batch-level quality control.
Contezolid CoA mostly includes findings from lab analyses of a specific batch. For each Contezolid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Contezolid may be tested according to a variety of international standards, such as European Pharmacopoeia (Contezolid EP), Contezolid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Contezolid USP).
